{"timestamp": 1771603380.1279836, "value": {"ticker": "GANX", "company_name": "Gain Therapeutics, Inc.", "short_name": "Gain Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 74616448, "float_shares": 34841342, "shares_outstanding": 38462085, "short_ratio": 2.81, "short_percent_of_float": 0.0799, "shares_short": 2976352, "shares_short_prior": 2666410, "insider_percent_held": 0.03399, "institution_percent_held": 0.21285, "total_cash": 8807353, "total_debt": 605278, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 10.243, "current_ratio": 2.522, "book_value": 0.164, "price_to_book": 11.829268, "operating_cashflow": -17301580, "free_cashflow": -9535148, "price": 1.94, "52w_high": 4.34, "52w_low": 1.41, "avg_volume": 1343468, "avg_volume_10d": 517810, "full_time_employees": 23, "audit_risk": 0, "overall_risk": 0}}